Research advances in the role of gut microbiota in chronic hepatitis B, chronic hepatitis C, and related liver diseases

VernacularTitle:肠道菌群影响慢性乙型肝炎、慢性丙型肝炎及相关肝病的研究进展
Author: Hui DENG ¹ ; Bin ZHANG ¹ ; Bin ZHU ¹ ; Zhayier DILIHUMAER ¹ ; Weixian WANG ¹ ; Chunxia GUO ¹ ; Dongliang YANG ¹ ; Xin ZHENG ¹ ; Junzhong WANG ¹ ; Baoju WANG ¹
Author Information

1. Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Publication Type:Reviews
Keywords: Hepatitis Viruses; Gastrointestinal Microbiome; Liver Cirrhosis; Liver Failure; Therapeutics
From: Journal of Clinical Hepatology 2022;38(5):1143-1147
CountryChina
Language:Chinese
Abstract: Hepatitis B virus infection and hepatitis C virus infection often progress to end-stage liver diseases such as liver cirrhosis, liver failure, and hepatocellular carcinoma, which endanger the life of patients. Recent studies have shown that gut microbiota are closely associated with chronic viral liver diseases. This article reviews the association of gut microbiota with chronic hepatitis B (CHB), chronic hepatitis C (CHC), and their related liver diseases and the research advances in therapies targeting gut microbiota against CHB and its related liver diseases, in order to provide more ideas for the clinical treatment of CHB, CHC, and their related liver diseases.